Você está na página 1de 35

Pfizer Biotechnology Ireland

A
B

Draft Standard Operating Procedure for Calibration


Pfizer Ireland Pharmaceuticals Maintenance Strategy

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

ATTACHMENT F.1

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC
ATTACHMENT F.1.DOC

Attachment F.1
Page 1

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

MAINTENANCE SOP
PFIZER SMALL SCALE MONOCLONAL ANTIBODY FACILITY
SHANBALLY IRELAND

CALIBRATION POLICY

Document No:
se

Draft
to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

This procedure is intended as an overview of the approach to equipment and instrument calibration at the
Shanbally MABS Small Scale Facility.

Role / Department

Name

Author

Engineering

Vincent Coleman

Reviewed By

Engineering

Declan J Murphy

Approved By

Engineering

Signature

Date

Liam OBrien

Co

ns
en

Approval

Revision History
Document
Revision

Date

Name

Reason for Update

29/07/08

Vincent Coleman

Original

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC
ATTACHMENT F.1.DOC

Attachment F.1
Page 2

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

TABLE OF CONTENTS

1.0

PURPOSE 4

2.0

SCOPE

3.0

APPLICABLE PERSONNEL

4.0

DEFINITIONS ACRONYMS AND SYMBOLS

5.0

RULES AND GUIDELINES 8

.
se
ru
he
ot

Calibrations
8
Instrument Specifications
8
Records
9
Selection and Use of Calibration Standards
11
Calibration Instruction and Instruction Numbers 11
PM Schedule Codes
12
Calibration Labels
12
Instrument Tolerances 12
Calibration Certificates 12
Calibration Intervals
13

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

5.1
5.2
5.3
5.4
5.5
5.6
5.7
5.8
5.9
5.10

SAFETY PRECAUTIONS 14

7.0

CREATING/MODIFYING INSRUMENT/PM/CALIBRATION INSTRUCTION RECORD


14

8.0

DEACTIVATING EQUIPMENT

15

9.0

ACTIVATING EQUIPMENT

16

10.0

REQUEST PM EXTENSION

16

11.0

PERFORMING CALIBRATIONS

17

Co

ns
en

6.0

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 3

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

1.0 PURPOSE
To provide an overview of the approach to instrument calibration at the Shanbally Small Scale
Facility (SSF), which establishes the requirements for calibration of equipment, instruments, and
standards used in production, storage, and testing that may affect the identity, strength, quality,
or purity of product.

2.0 SCOPE
This calibration procedure applies to the SSF, defining the responsibilities, criteria, and
documentation requirements for the calibration of equipment and instruments used on site.
Calibration of all production and facility equipment is included in the scope of the SOP.
Calibration of Laboratory equipment is excluded.

3.0 APPLICABLE PERSONNEL

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

This procedure applies to all Pfizer colleagues and to contractors who request, perform or
approve calibration activities.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 4

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

4.0 DEFINITIONS ACRONYMS AND SYMBOLS


Calibration
Set of operations that establish, under specified conditions, the relationship between values of
quantities indicated by a measuring instrument or measuring system or values represented by a
material measure or a reference material, and the corresponding values realised by standards.
Calibration Interval
The interval, in days, between successive calibrations.
Calibration Instruction Number

The unique number assigned by the Calibration Co-Coordinator to a new calibration


task.

se

Calibration Standard
This is the designated measuring equipment used routinely to calibrate or check
measuring instruments, or material measures. This is also referred to as Working
Standard, Transfer Standard or Reference Standard.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

Calibration Range
Specified range over which the instrument is calibrated. This should at least cover the
normal operating range.
cGMP
Current Good Manufacturing Practices.

Co

ns
en

CMMS
Computerised Maintenance Management System. The integrated modular computerised
system used at the SSF to control all maintenance and calibration activities.
Calibration Co-ordinator
Responsible for the overall management of the plant calibration programme.
CMMS Administrator
Responsible for the CMMS administration of all maintenance related activities within the
plant.
Calibration Instructions
A set of instructions which describes the process for calibrating an instrument.
Device Input & Output Range
Range over which instrument is capable of measuring. Provided in manufacturers
specification.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 5

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Environmental Critical Instruments


An instrument that is used to assure environmental compliance and which have
appreciated environmental implications if it fails on demand.
GMP Critical Instruments
Instruments used directly to manufacture, process, package and/or hold pharmaceutical
products or drug substances and as a result whose failure may directly affect product
quality.
Increment
Smallest difference between indications of a displaying device that can be meaningfully
distinguished.
Instrument/Standard ID Label
The label containing the Instrument/Standard ID Number.

ru

se

Instrument/Standard ID Number
The unique number assigned by the Calibration Co-ordinator to each loop or individual
instrument/standard that is not part of a loop.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

Loop Calibration
Calibration of a group of instruments connected together to monitor, or control a process
variable.
Non Critical Instruments
Instruments whose function is important to the operation or efficiency of parent
equipment but whose failure are deemed to have no effect on product quality

Co

ns
en

Normal Operating Range (NOR)


Specified range within which the process NORMALLY operates.
Process Control Limit
The maximum allowable error in the measured reading within the process.
QAR Notification Form
A report generated to notify relevant personnel when GMP critical equipment is found
operating outside of design parameters.
Standard Calibration Label
The label containing the calibration information for a calibration standard.
Safety Critical Instruments
An instrument which is used to assure the safety of personnel and equipment and which
has appreciable safety implications if it fails on demand.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 6

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Traceability
Property of the result of a measurement or the value of a standard whereby it can be
related to stated references, usually national or international standards, through an
unbroken chain of comparisons all having stated uncertainties.

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

Unit Of Measure (UOM)


Unit Of Measure

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 7

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

5.0 RULES AND GUIDELINES


5.1

Calibrations

5.2

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

1. The Engineering Department is responsible for the administration of the Calibration System
and that the Calibration program is reviewed on an annual basis. A work order is generated in
the CMMS and the Engineering Department reviews the Calibration System.
2. All calibrations will be scheduled through the CMMS.
3. Calibrations will be loop calibrations where possible.
4. One record will be generated in the CMMS for each instrument or loop.
5. Where applicable the CMMS record will reference the P&ID tag number of the instrument or
loop and the instrument ID number as assigned by the calibration co-ordinator.
6. The instrument ID number will be assigned to the instrument or loop when the CMMS record
is generated.
7. Calibration shall be conducted at a minimum of three points (e.g. upper optional range, lower
optional range and NOR), if possible. For instruments that cannot be calibrated at three
points, the points to be included in the calibration shall be defined and justified.
8. Calibrations will be scheduled and performed in accordance with best calibration and cGMP
practices and applicable safety and environmental policies
9. Instruments will be calibrated over their device Input & Output range, where practical.
10. Where it is not practical to calibrate the instrument over the full range, the instrument must at
a minimum; be calibrated over the normal operating range.
11. Measurement instruments will be re-calibrated if dropped jarred or damaged.
12. Loop components must be individually calibrated prior to installation in the loop or in the
event of overall loop failure during routine calibration of the loop.

Instrument Specifications

ns
en

13. Instrument specifications shall be established prior to defining the calibration method for the
instrument and shall be based on the requirements of the application and specific
parameter(s) that the instrument is intended to measure.
Co

14. Instrument Specification shall include, and are not limited to:
Definition of required tolerance and precision
Expected process parameter values, including unit of measure
Expected NOR of the process parameter values.
Acceptable Tolerance
Instrument stability requirements
Safety and environmental consideration.
The instrument specification record shall be attached to the Instrument Change
Record Form. Prior to removing an instrument from service, a final calibration shall
be performed, if possible (i.e. instrument still functional), to verify that the
instrument is still within tolerance.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 8

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Initial As found data shall be recorded prior to removing an instrument


from the calibration schedule, performing and upgrade, or before an
instrument is moved. If the instrument is not calibrated prior to a move, the
justification must be documented and approved by the site Quality Authority.

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

15. Personnel requesting Corrective Maintenance for GMP instruments are responsible for
completing a QAR form and for releasing a CM work order, as applicable
16. Calibrations shall not be performed unless environmental conditions are suitable for both the
measurement equipment and the calibration standard used.
17. Where a PM is to be extended for greater than 30% of the PM frequency (either single or
cumulative extensions), QA approval must be obtained by opening a planned QAR.
18. Criticality determination for instruments is as per the following: GMP, Safety,
Environmental, GMP and Safety, GMP and Environmental and non-critical are CLS01,
CLS02, CLS03, CLS04, AND CLS09 respectively
19. Instruments will be considered overdue for calibration after the due date if the calibration has
not been completed. A calibration due-date extension may be granted provided that
reasonable assurances can be made based on the instrument calibration history and/or a
statement from the original equipment manufacturer that continued equipment use for a
limited time would not affect performance.
20. A QAR Notification (QAR) form must be completed if a GMP critical instrument is not
calibrated by the due date and the associated equipment is used to manufacturer product.
21. If a GMP critical instrument is found to be out of tolerance, a QAR must be initiated and
must include a product quality impact assessment carried out in conjunction with the
process/manufacturing owner and the person performing the calibration.
22. A full instrument criticality assessment must be made for all new instruments.
23. New equipment will be tagged Do Not Use until the criticality status and calibration
requirements of instruments associated with it are evaluated.
24. Instruments already classified as Non Critical are calibrated at the sole discretion of
engineering.
25. Stationary instruments must be re-calibrated after movement.
26. Any instrument that has been repaired must be re-calibrated before being returned to service.
27. Trained personnel only will carry out calibrations and are detailed on file with HR (Human
Resources) and the Calibration Co-Ordinator.
28. Learning records will be maintained for all personnel engaged in performing and
administering the calibration program.
29. Calibrations performed by vendors or contract services must meet the requirements of this
document.
30. Vendors to be reviewed and audited as deemed necessary by the site quality authority.
31. Vendors/contractors must have procedures that assure the accuracy and traceability of their
reference and test equipment.
32. All efforts should be made to keep instruments as accurate as possible. Thus instruments
should be adjusted even if within tolerance but approaching the limits.
33. Individual calibration tasks must be maintained for each instrument calibrated. These tasks
can be a guideline described in the manufacturers manual or written procedures that may be
contained in CMMS.

5.3

Records
34. An instrument record must be maintained for each loop or instrument. The instrument record
must provide sufficient information to set up a replacement loop and/or instrument, if
necessary.
35. For original loop records, hard copies of the element/transmitter certificates will be attached
and filed with the original loop calibration certificate in the QA DCC (document control

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 9

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

36.
37.

centre). All subsequent loop calibration certificates will be filed with these. This file will be
the record for loops and the loop components.
The calibration files will be organised by Instrument ID number.
A calibration certificate will be completed for each calibration carried out and then filed in
the calibration files.
Calibration intervals will be specified in days.
The next due date for calibration will be calculated from the date done.
All calibration activities must be recorded in the relevant Equipment Logbook.
The instrument or loop record must include the following
Instrument ID number
Instrument or loop description
System number that the instrument or loop is part of (as applicable)
Criticality
P & ID tag number of the instrument or loop
Date last calibrated ( as applicable)
Type
Manufacturer
Model number
Serial number
Location
Device Input/Output range
Calibration Failure Limit
Device
or loop calibration interval
Calibration Instruction reference
Operating range ( where applicable)
Process Control Limit (where applicable)
to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

38.
39.
40.
41.

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Nominal Test points

ns
en

Note: Prefixes relating to nominal test points for weigh scales include:
Co

CTR: Centre (Point)


FRT: Front Right (Load cell)
FLT: Front Left (Load cell)
BRT: Back Right (Load cell)
BLT: Back Left (Load cell)
RPT: Repeatability (Test)
The point of reference for the load cell locations being the local indicator.

42. For in-house standards, a calibration certificate shall be prepared based on supporting
raw data. The certificate shall include, and not be limited to:

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 10

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Description of standard
Date the standard was established
Signature of the person preparing the standard
Date standard must be recertified or replaced
Handling or storage conditions for the standard
Reference to a method or task used to establish the standard
Accuracy and precision of the standard.
5.4

Selection and Use of Calibration Standards

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

43. Standards used for calibrating measurement equipment will have the capability for accuracy,
stability and range needed for their intended use.
44. The calibration standard must always be more accurate than the instrument under test. Where
possible the uncertainty ratio should be 1:4. Where this is not practical, a less accurate
standard may be used with the approval of site QA.
45. Calibration certificates will support all calibration standards used in the calibration system.
Certificates for Pfizer standards will be filed in Pfizer document control. Certificates for
contractor standards must be available on request.
46. A calibration standard, when not in use, shall be stored in a secure manner which prevents
unauthorised adjustment.
47. Standards must be safe to operate in the specific process area in which the equipment is
being used. Ensure the standards are clean prior to use to prevent Cross Contamination.
48. The storage environment shall meet the standards storage requirement.
49. Calibration Standards used in calibrating measurement equipment will be: Traceable to one
or more of the following; the National Institute of Standards and Technology (NIST), the
National Physical Laboratory U.K. (NPL), the United Kingdom Accreditation Service
(UKAS), the National Standards Authority of Ireland (NSAI) or equivalent institutes.
50. Where applicable all calibration standards must be added to a Portable Appliance Testing
(PAT) schedule.

5.5

Calibration Instruction and Instruction Numbers


51. An instruction for the calibration of each type of Instrument (e.g. pressure gauge,
temperature transmitter, flow meter) shall be reviewed and approved by the system
expert/designee to ensure that the instructions are technically correct and are approved by the
site Quality Authority, Environmental Health and Safety principles shall be consulted if
required.

The format for Calibration Instruction numbers is:


CI-sequential number-revision number
For example, the first revision of the fiftieth calibration instruction would be
numbered: CI-0050-01.
Instructions will be filed in equipment files or calibration task files under calibration
instruction number.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 11

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

5.6

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

PM Schedule Codes
52. A PM schedule code will have the same code as the instruction code to which it is linked to
in CMMS.

5.7

Calibration Labels
53. Calibrate before use: the calibration label used for all calibrated loops or instruments that
must be calibrated before use. It contains the calibration date, signature of the person
performing the calibration, and the required calibration interval.
54. Do not use: the label attached to a loop or instrument that has not been calibrated, is over-due
for calibration, is not operating correctly, or must not be used for other reasons.
55. Instrument ID Labels: for loops, the Instrument ID label will be attached as close as
practicable to the measuring element of the loop.
56. An instruction for the calibration of each type of Instrument (e.g. pressure gauge,
temperature transmitter, flow meter) shall be reviewed and approved by the system
expert/designee to ensure that the instructions are technically correct and are approved by the
site Quality Authority, Environmental Health and Safety principles shall be consulted if
required.

5.8

Instrument Tolerances

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

57. Loop and instrument calibration tolerances will be based on manufacturers'


recommendations, process requirements, and stability of the instrument, purpose and
accuracy and/or historical calibration data for similar instruments.
58. Loop tolerances will be based on the cumulative effect of the individual component
accuracies, taking into account the resolution of the display.

For example:

Co

ns
en

Sensor 0.25C,
Transmitter 0.05C,
Input card 0.1C,
Display reads out in 0.5C increments,
Loop tolerance should be 1C.

5.9

Calibration Certificates
59. A calibration certificate must be completed for each calibration carried out.

60. The calibration record must include the following:

Instrument ID number

Instrument or loop description

Manufacturer

Model

Serial Number

Location

Device Input/Output Range

Calibration Failure Limit

Nominal test points

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 12

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Calibration interval

Calibration Instruction reference

Reference standards used for calibration, identification number and


calibration due date.
As found calibration data

As left calibration data, if applicable

Reference to QAR Form, if applicable

Instrument criticality

Signature of person performing the calibration

Date of calibration

Signature of person approving the calibration

Date of approval

Comments

Calibration Intervals

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

5.10

ot

he

ru

se

Co

ns
en

61. Calibration intervals will be specified in days.


62. The next due date will be calculated, in days, from the date done.
63. Calibration intervals will be based on manufacturers' recommendations, stability of the
instrument, and consequence of calibration failure, purpose and accuracy and/or historical
calibration data for similar instruments.
64. Calibration interval must not exceed 365 days for instrument classified as GMP critical.
65. A calibration interval may be lengthened if the instrument or loop remains within tolerance,
without adjustment, for 3 successive calibrations.
66. A calibration interval may be shortened as a corrective action or part of one if the instrument
or loop is outside tolerance for two successive calibrations.
67. The new interval should be half the previous interval and cannot be less than 1 day, except
where instruments are designated as Calibrate Before Use.
Note: corrective actions to instrument failure are treated on an individual basis based on the
instruments criticality, use within the process, and closeness to the product, current tolerance
and previous calibration history.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 13

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

6.0 SAFETY PRECAUTIONS


Ensure you read the relevant Risk Assessments

7.0 CREATING/MODIFYING
INSRUMENT/PM/CALIBRATION INSTRUCTION
RECORD
Person

Step

Action

Responsible
Project/request

1.

originator

Tag the instrument appropriately to prevent its use until equipment


maintenance and validation/qualification determinations can be

2.

he
ot

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

type changes

ru

se

completed. Note this step is only applicable for Instrument entry

Complete the Entry/Change form and issue to the Engineering


dept.

Engineering

3.

Review information and issue to relevant approvers.

Relevant

4.

Review and, if acceptable, approve request and return to CMMS

5.

Administrator
Project/request
originator

Enter relevant data from Record Entry/Change form into CMMS

Co

CMMS

administrator.
ns
en

Approver

and return paperwork to originator.

6.

Verify that equipment is appropriately tagged with correct


equipment code (only applicable for Instrument entry/changes) and
file paperwork in DCC.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 14

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

8.0 DEACTIVATING EQUIPMENT


Person

Step

Action

Responsible
Request

1.

Originator

Identify the equipment to be de-activated and tag it Deactivated


If

Then

Scrapping Equipment

Raise a calibration work

order in order to calibrate the


instrument prior to removal.

Dispose of it

appropriately and inform the


finance department.
Taking out of service

temporarily

order in order to calibrate the

Raise a calibration work

Calibration Coordinator

2.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

instrument prior to removal.

Prepare the equipment as

necessary, for inactive period.

Deactivate the equipment and associated PM schedules in CMMS as


appropriate.

Co

ns
en

/Designee

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 15

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

9.0 ACTIVATING EQUIPMENT


Request

1.

Originator
Calibration Co-

Raise a Calibration work order in order to calibrate the instrument prior to


installation.

2.

Activate the equipment and associated PM schedules in CMMS.

ordinator
/Designee

10.0 REQUEST PM EXTENSION


Person

Step

Action

Responsible
1.

Contact engineering with request for extension

Engineering

2.

Make determination on validity of request and amend target date as


to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

Requestor

appropriate.
3.

Record justification in comments section of work order and where

Co

ns
en

appropriate seek approval by QA.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 16

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

11.0 PERFORMING CALIBRATIONS


Person

Step

Action

Responsible
Calibration Co-

1.

Release a work-order for the scheduled calibration.

ordinator /

2.

Distribute the work-order to the colleague responsible for the calibration.

designee

3.

Apply for an extension to the work order, if the calibration cannot be


completed by the due date.
If

Then

Extension is granted

The calibration must be completed by


the revised due date & the calibration
label must be replaced.
Tag equipment DO NOT USE on the
.

Extension is rejected

he

ru

se

calibration due date and until calibration

Technician

4.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

is completed.

Follow the calibration instruction attached to or referenced by the workorder.

5.

Complete the calibration record and ensure that each person involved in
the work signs the form. Attach a calibration label showing the instrument

Notify an area rep which instrument was worked on and where possible
Co

6.

ns
en

ID number, calibration date, next due date and initials.

request an equipment dry run prior to returning equipment to normal


operation. (only applicable when calibrating a critical parameter)

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 17

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Person

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Step

Action

Responsible
Technician

7.

Enter the calibration data into CMMS.


If

Then

As-found data is

un-acceptable and the

accordance with SOP DEV-1002

instrument is GMP critical

Event and Deviation System.

Complete a QAR form in

When entering data into the

CMMS, enter the QAR number in

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

the work order Comments field.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 18

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Technician

As-left data is un-

acceptable

and seek a replacement.

Tag equipment DO NOT USE

If replacement is like for like

follow the procedure,


Creating/Modifying Instrument records
in the Calibration Program outlined in
this SOP. Record the calibration results
for the replacement instrument in the
left results section of the certificate.
Enter the serial number of the original
and replacement instrument on the
work order. Clearly identify that the
replacement was carried out in the

se
ru

If the replacement is not a like for

he

comments section of the work order.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

like change, complete a change


request form (CRF) and enter the CRF
number in the comments section on the
work order. Request the calibration coordinator / designee to remove the

ns
en

existing instrument, and setup the

Co

replacement as per Creating/Modifying


instrument records in the calibration
program

8.

Record calibration work in appropriate Equipment logbook.

9.

Forward the completed Calibration Record to the Calibration Coordinator/ Designee for approval.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 19

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Calibration Co-

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

10. Review the Calibration record and ensure the calibration was carried out

ordinator /

in accordance with the task associated with the instrument. Confirm that

Designee

the data on the record is accurate and corresponds to the data entered into
the CMMS.
11. Approve the calibration work order.
12. Forward the completed calibration records to the QA Document Control
Centre (DCC). Scheduled calibrations are filed by Instrument ID number.
13. Monitor the completion of calibrations throughout the scheduled period to
notify relevant colleagues if calibrations are overdue.

Generate the following report.


to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

15.

Facilitate the execution of calibrations throughout the facility.

se

14.

A weekly Calibration due report to review all overdue

Co

ns
en

and due calibrations for the coming month.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 20

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Pfizer Ireland Pharmaceuticals

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

PIP Maintenance Strategy

Co

ns
en

Revision 1

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 21

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Table of Contents
Section

Description

Page

1.0

Vision

2.0

Purpose

3.0

Scope

4.0

Regulatory Compliance & Environmental, Health and

Safety
Organisation and Administration

6.0

Responsibilities

7.0

Partnerships

8.0

Asset Management

9.0

Work Control Systems

10.0

Work Planning and Scheduling

11.0

Reliability Plans

12.0

Predictive and Preventive Maintenance

13.0

Maintenance Metrics

10

14.0

Materials Management

11

15.0

Cost Management

11

16.0

Maintenance Interface

12

17.0

Maintenance Evaluation and Continuous Improvement

12

18.0

Training and Development

12

19.0

Maintenance Teams and Knowledge Sharing

13

20.0

Communication

13

21.0

Abbreviations

14

22.0

Approvals

15

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

5.0

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 22

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

1.0 Vision
The Global Maintenance Initiative is outline as follows:
Program to implement Reliability Based Maintenance practices consisting of assessments, master
planning, training, tool implementation, and continuous improvement.
The PIP Maintenance Team will ensure alignment with the global GMI vision by means of the following:

he

ru

se

Develop processes to enable Continuous Improvement of all aspects of Maintenance as a


Business; through the use of both RFT and GMI tools.
Utilise a data driven approach to enhance the quality and compliance of maintenance operations.
Ensure safety of colleagues and facilities through effective and compliant operation of
maintenance activities.
Promote leadership in maintenance departments and increase job satisfaction
Engage with other functions across product Value Streams to ensure Maintenance continues to
deliver value and ensure strong customer service.
Maintenance functions will deliver cost savings to the overall business in PIP.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

2.0 Purpose

This strategy document outlines the elements for performing maintenance at all Pfizer Ireland
Pharmaceutical Facilities.

ns
en

This document is intended to put the processes in place to allow Pfizer Ireland Pharmaceuticals to strive
towards maintenance excellence for the purpose of supporting operational excellence through equipment
reliability, compliance and safety whilst utilising resources in an effective and efficient manner.
Co

The expected outcomes of this strategy include:

Optimised asset life cycle costing and overall equipment effectiveness. (OEE)
Reliability plans based on reliability practices and techniques.
Reduced risk in areas including regulatory compliance, environmental, health and safety.
Improved organisational effectiveness and engagement of maintenance colleagues.
Managing maintenance as a business based on metrics, monitoring and reporting.
Effective cost management
Effective partnering between maintenance and operations.
Increased sharing of knowledge and expertise across Pfizer Ireland Pharmaceuticals
Alignment with Right First Time (RFT)
Continuous improvement

3.0 Scope
This document applies to the following at all Pfizer Ireland Pharmaceuticals Facilities
Site Engineering/Maintenance Teams
Equipment Owners
Operations
J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE
APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 23

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Site Leadership Teams


Right First Time
Quality Operations
EHS

4.0 Regulatory Compliance & Environmental, Health and Safety


Maintenance activities performed by internal and external parties must be developed, planned and
executed in compliance with all regulatory guidelines, standards and policies.
Maintenance teams should promote a safe, compliant and clean working environment. Quality and
compliance should be addressed in the execution of all maintenance activities. Furthermore, contingency
plans must be in place to deal with unexpected adverse events.

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

These plans shall be developed in partnership with operations and communicated to all stakeholders.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 24

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

5.0 Organisation and Administration


All maintenance roles should be clearly defined and documented.
Resource plans should be developed from metrics to determine staffing levels and shift allocations.
Insourcing/outsourcing decisions should be based upon customer requirements, core competencies,
associated risks, local market conditions and other relevant factors.

6.0 Responsibilities
Leadership:
Leadership should promote reliability based maintenance concepts to Operations and across site
partnerships

Engineering

he

ru

se

and maintenance leaders are responsible for communicating the maintenance


strategy to their maintenance teams, applying the strategy and setting maintenance performance
objectives.
to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

Site Maintenance Teams:

The site maintenance teams shall be responsible for the following:

Co

ns
en

Ensure that planned equipment maintenance and calibrations are performed in a timely manner to
prevent unplanned failure of critical equipment and ensure compliance with regulatory
requirements.
Perform corrective actions to correct equipment failures, prevent potential equipment failures and
ensure equipment safety.
Perform root cause failure analysis on equipment failures.
Continuous improvement in maintenance activities through equipment modification, PM
optimisation, introduction of reliability techniques and implementation of RFT techniques.
Maintaining the CMMS system to ensure that equipment, instruments, maintenance schedules,
personnel and spare parts are correctly set up and maintained.
Development of asset care plans for new equipment.
Ensure that colleague training, development and performance management systems are in place
and effectively delivered.
Ensure that training plans are based on an overall training program that is developed in
conjunction with the needs of the business and maintenance colleagues.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 25

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Project Engineering:
Project Engineering shall be responsible for

Providing relevant details for set up of equipment on the CMMS system.


Engaging with maintenance colleagues for design and selection of new equipment.
Providing necessary handover documents for equipment.
Engaging in the development of asset care plans for new equipment.

Equipment Owners:
Equipment owners shall be responsible for
Notification to maintenance of equipment issues that may affect the reliability of that
equipment.
Engage in RCM, FMEA and RCFA activities in relation to the equipment.
Operations:

ru

se

The operations team are responsible for

Co

7.0 Partnerships

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

Operating equipment in a manner that supports reliability


Monitoring equipment operation and highlighting potential issues that may impact on
equipment performance
Liaising with the maintenance planner and scheduler to ensure that the production schedule
aligns with the maintenance schedule so that planned maintenance and calibrations can be
performed within their required target dates
Engaging in RCM, FMEA & RCFA activities in relation to equipment

Equipment reliability and maintenance excellence is dependant on the partnerships between site
maintenance teams, equipments owners and equipment operators. Partnership agreements will ensure that
all stakeholders understand their role in the maintenance excellence process.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 26

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Partnership agreements shall contain the following:


Operations expectations of maintenance

Response times to emergency situations


Production Support requirements
Use of RCFA to eliminate recurring issues
Measures of reliability
Optimisation of planned maintenance activities to reduce impact of maintenance on equipment
availability
Prioritisation of work
Maintenance expectations of operations
Methods of reporting equipment issues
Agreements for equipment downtime to perform maintenance
Identification of potential equipment issues

ru

se

Engagement in RCFA for recurring issues

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

8.0 Asset Management

Assets shall be uniquely identified using an identification scheme structured into asset classes based on
equipment characteristics.

ns
en

All maintenance activities performed on an asset whether performed internally or externally, planned or
unplanned shall be recorded in the CMMS to ensure a complete and accurate asset history.

Co

9.0 Work Control Systems


A computerised maintenance management system (CMMS) shall be deployed to ensure proper work
control, regardless of who actually executes the work. The CMMS is essential for scheduling work and
resources, gathering equipment history reports for improvement purposes and managing maintenance
costs.
The work orders generated from the CMMS will contain sufficient information to enable a standardised
workflow that moves through eight phases: Request, Confirm, Plan, Schedule, Execute, Completion,
Review and Close out.
Approvals at the appropriate stages in the process shall ensure the quality and cost effectiveness of the
process.
Work Order Types:
Work order types are categorised as follows
Planned preventive work: This is work that is placed on a work schedule based on timed intervals or
equipment usage. This work is performed so that potential issues can be addressed prior to those issues
causing an unplanned equipment failure.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 27

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

Planned corrective work: This is corrective work that has been identified that could cause a potential
unplanned equipment failure but the potential failure is not imminent and this corrective work can be
placed on the work backlog and planned and scheduled.
Emergency Work: This is work that is required to be performed immediately to prevent failure or
restore operation of critical equipment.
Production Support Work: This is non repair work that is required to support the production operation
such as line set up, equipment operation assistance, scheduling assistance, etc.
Calibration: Periodic instrument calibrations.
Administration: Non repair work such as data retrieval, training, meeting attendance, etc.
CBM / Predictive: Work carried out utilising technologies that will monitor equipment performance and
identify potential failures based on results.

se

10.0 Work Planning and Scheduling

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

Maintenance work planning and scheduling is essential for maintenance excellence and brings benefits in
terms of efficiencies through having work available for maintenance resources.
The role of the maintenance planner and scheduler is to develop job plans for planned work to include
task lists, spare parts requirements, special tools required, work prioritisation and resource requirements.

Co

ns
en

The planner and scheduler shall also be responsible for liaising with maintenance supervisors and
operations to ensure that equipment and resources are made available for routine maintenance to be
performed, ensuring that equipment is reliable and regulatory and statutory are met.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 28

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

11.0 Reliability Plans


Reliability plans shall be developed in accordance with the Pfizer Ireland Pharmaceutical reliability
strategy (*TO BE DEVELOPED)
The reliability plans shall incorporate reliability based maintenance principles, namely:

Asset identification
Criticality assessment
Asset performance standards and requirements
Determination of failure modes and effects
Periodic evaluation and continuous improvement.

Reliability plans are the specific tasks performed on an asset. These plans shall address all elements of
asset utilisation and performance including quality, safety, environmental protection, uptime
requirements and throughput.

he

ru

se

Criticality assessment tools shall be utilised for assets, this provides the basis for the reliability plan of an
asset.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

Periodic reviews of criticality assessments and reliability plans shall be performed and any modification
or usage change of an asset shall also trigger a review of the criticality assessment and reliability plan.

12.0 Predictive (PdM) and Preventive (PM) Maintenance

Co

ns
en

Proactive maintenance activity shall be promoted by maintenance teams. Inspections based on actual
measurements and data are preferred because they are typically more effective than those based on a
technicians senses.
Predictive maintenance techniques are most effective and shall be utilised where possible. These
techniques are intended to identify the onset of a specific failure mode objectively through the
monitoring, measuring and trending of changes in equipment condition.
Vibration analysis, ultrasonics, thermography and electrical circuit evaluation are among the most
common PdM tools that can be applied by maintenance teams.
In addition, preventive maintenance practices such as inspection, adjustment, cleaning and lubrication
shall be utilised in the reliability plan.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 29

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

13.0 Maintenance Metrics


Metrics will allow the maintenance team and partners to evaluate performance and target areas of
opportunity for continuous improvement in equipment reliability and maintenance processes.
Maintenance metrics are essential in the approach of managing maintenance as a business in order to
provide the best value to our partners and customers.
Maintenance Metrics can be divided into three categories:
1: PGE Core Metrics These are metrics that have been pre-defined by the Global Maintenance Team as
base metrics for a maintenance organization. The purpose of these metrics is to assist in strategical
decision making at a global, PIP and local level. These metrics are reported monthly to ILT, PGE,
Engineering Team Leaders and Maintenance Team Leaders. These metrics are also generally shared with
maintenance organisations elsewhere in the globe for knowledge sharing purposes. (*METRICS TO BE
DEFINED)

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

2: PIP Additional Metrics These metrics are defined by the PIP maintenance team leaders as metrics
that would provide benefit for the operating environment of the PIP Sites. The purpose of these metrics is
to assist in strategic decision making at a PIP and local level. These metrics are reported monthly to ILT,
PGE, Engineering Team Leaders and Maintenance Team Leaders. (*METRICS TO BE AGREED BY
MTLs)
3: Site Specific Metrics These are metrics that may be defined at a site level and are relevant to the site
maintenance teams specific needs. These metrics are recorded at the discretion of the site and are utilised
to assist in tactical decision making in relation to equipment reliability and maintenance processes.
Site specific metrics may include but should not be limited to the following:

ns
en

OEE Measurement
Maintenance Cost Reports (By site, department and asset)
Past Due Work
Backlog Measurement
Percent Production Support
Stock outs of critical spares
Environmental releases attributable to maintenance
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 30

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

14.0 Materials Management


An effective materials management program is necessary to ensure the availability and delivery of parts,
tools, equipment and materials for the execution of the reliability plans.
This program balances inventory levels and the cost of inventory. It also ensures suppliers are managed
to provide Pfizer Ireland Pharmaceuticals with the best possible supply agreements.
Where possible, the Ireland sites should regionalise stockrooms and/or leverage availability of parts and
suppliers.
The materials management program shall address items including:
Material identification and storage
Inventory management
Controls
Replenishment systems
Stock codes linked to assets

ot

he

ru

se

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

15.0 Cost Management

Budgets shall be developed based upon predetermined maintenance activities including preventive
maintenance, historical levels of unplanned maintenance, customer support requirements, materials, tools
and equipment needs etc.

ns
en

The EMU cost template shall be used as a tool to capture and trend costs. Cost tracking and reporting
shall be performed on a monthly basis and compared against targets and benchmarks.
Co

Cost data collected as the asset level is preferred as it can be used to aid decisions to repair, refurbish or
replace the asset.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 31

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

16.0 Maintenance Interfaces


Maintenance organisations are partners in the operations that they support, it is expected that
maintenance teams will have regular communications and meetings with their partners.
Reliability plans shall be reviewed with the asset owners to establish appropriate service levels and user
requirements.

17.0 Maintenance Evaluation and Continuous Improvement


Continuous improvement is enabled by measuring performance, setting improvement goals, tracking and
reporting progress towards those goals.
Pfizer Ireland Pharmaceutical maintenance teams will measure, track and report key performance metrics
as recommended by the Global Maintenance Team.

ru

se

Metrics must be made visible to operations and be well understood by all maintenance colleagues.

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

Regular assessments of maintenance operations shall be conducted to identify progress against each sites
maintenance master plans, good practices and external benchmarks.

18.0 Training & Development

Co

ns
en

All maintenance colleagues will be competent and qualified to perform their duties through a
combination of their education, training and experience. There will be documented evidence available
for each individuals training status. Required training for the job will be identified through a job function
curricula which will be available for each job position. Colleagues will be responsible for ensuring they
are adequately trained prior to undertaking any task.
Every colleague will be encouraged to identify developmental opportunities to enhance their skills and
qualifications; this will be done with the support of maintenance leadership.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 32

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

19.0 Maintenance Teams and Knowledge Sharing


To leverage the depth and breath of maintenance knowledge at Pfizer Ireland Pharmaceuticals,
maintenance teams shall be established and will regularly meet to share experiences and knowledge.
Leveraging items such as criticality assessments, toolkit applications such as PM optimisation, planning
and scheduling, supply and service agreements etc, is essential to strive towards a maintenance
excellence organisation.
The PIP maintenance leaders team shall work together on tactical implementation of their goals and
objectives and stay closely linked to the Global Maintenance Team.
Individual maintenance team leaders are expected to support the Ireland Maintenance Team by:
Participating in meetings
Staying abreast of activities
Providing input in the form of good practices, learnings etc
Utilising communications vehicles such as E-room/Sharepoint.
ru

se

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

20.0 Communications

Co

ns
en

Communications vehicles shall be used to keep all stakeholders informed and to seek feedback on all
maintenance activities at each Ireland site. Communications processes between maintenance teams will
be essential to promote knowledge sharing, good practices and successes. Communications at site,
regional, area and global levels should be utilised.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 33

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

21.0 Abbreviations

CBM

CONDITIONED BASED MONITORING

CMMS

EHS

COMPUTERISED MAINTENANCE
MANAGEMENT SYSTEM
ENGINEERING MAINTENANCE AND
UTILITIES
ENVIRONMENTAL, HEALTH AND SAFETY

FMEA

FAILURE MODE AND EFFECTS ANALYSIS

OEE

OVERALL EQUIPMENT EFFECTIVENESS

PdM

PREDICTIVE MAINTENANCE

PIP

PFIZER IRELAND PHARMACEUTICALS

PM

PLANNED MAINTENANCE

RCFA

ROOT CAUSE FAILURE ANALYSIS

RCM

RELIABILITY CENTRED MAINTENANCE

RFT

RIGHT FIRST TIME

Co

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

EMU

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 34

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Pfizer Biotechnology Ireland

Pfizer Monoclonal Antibodies Small Scale Facility


IPPC Licence Application

22.0 Approvals

Approved By/Date:

_________________________________
Eugene O Callaghan, GMI Facilitator

_________________________________
Michael Cohalan, MTL Ringaskiddy

Approved By/Date:

Approved By/Date:

_________________________________
Michael Cleere, ETL LIAPI

_________________________________
Ryan Cleary, ESM Dublin

Approved By/Date:

Approved By/Date:

ns
en

to
f c Fo
op r i
yr ns
ig pe
ht ct
ow ion
ne pu
r r rp
eq os
ui es
re o
d nl
fo y.
ra
ny

ot

he

ru

se

Author/Date:

_________________________________
Jim Conway, MTL LOAPI

Approved By/Date:

Approved By/Date:

_________________________________
Michael Boyle, ETL Sponsor

_________________________________
Jim Brinkman, PGE Sponsor

Co

_________________________________
Tom Dineen, FCO LODP

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT
F.1.DOC

Attachment F.1
Page 35

Arup Consulting Engineers


24 September 2008

EPA Export 26-07-2013:01:46:19

Você também pode gostar